Works matching IS 08991987 AND DT 2023 AND VI 62 AND IP 7
Results: 16
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1073, doi. 10.1002/mc.23547
- By:
- Publication type:
- Article
Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1062, doi. 10.1002/mc.23546
- By:
- Publication type:
- Article
Withaferin A inhibits breast cancer‐induced osteoclast differentiation.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1051, doi. 10.1002/mc.23545
- By:
- Publication type:
- Article
Transcriptomic identification of differentially expressed genes in Levonorgestrel resistant endometrial cancer cell lines.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1038, doi. 10.1002/mc.23544
- By:
- Publication type:
- Article
Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1025, doi. 10.1002/mc.23543
- By:
- Publication type:
- Article
PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1009, doi. 10.1002/mc.23542
- By:
- Publication type:
- Article
Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1001, doi. 10.1002/mc.23541
- By:
- Publication type:
- Article
A variant in CYP26B1 associated with esophageal squamous cell carcinoma risk by affecting retinoic acid metabolism.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 991, doi. 10.1002/mc.23540
- By:
- Publication type:
- Article
Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 975, doi. 10.1002/mc.23539
- By:
- Publication type:
- Article
LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 963, doi. 10.1002/mc.23538
- By:
- Publication type:
- Article
Dual role of sprouty2 as an inhibitor of RAS/ERK‐driven proliferation and a promoter of cancer invasion in KRAS wild‐type colorectal cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 951, doi. 10.1002/mc.23537
- By:
- Publication type:
- Article
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c‐Myc signaling.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 940, doi. 10.1002/mc.23536
- By:
- Publication type:
- Article
MYO1B as a prognostic biomarker and a therapeutic target in Arecoline‐associated oral carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 920, doi. 10.1002/mc.23535
- By:
- Publication type:
- Article
Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T‐cell acute lymphoblastic leukemia harboring a cryptic ETV6‐NTRK3 fusion.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 899, doi. 10.1002/mc.23534
- By:
- Publication type:
- Article
PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 907, doi. 10.1002/mc.23533
- By:
- Publication type:
- Article
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 895, doi. 10.1002/mc.23429
- Publication type:
- Article